Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04360538 · ClinicalTrials.gov registry record
Long Term Outcomes of Patients With COVID-19
A clinical trial of COVID-19 and Critical Illness, sponsored by University of Chicago.
- Active
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT04360538: Active study of COVID-19 and Critical Illness, sponsored by University of Chicago.
NCT04360538 is a study of COVID-19 and Critical Illness that is active but no longer recruiting, run by University of Chicago. The registered enrollment target is 500 participants, below the 38,463-participant average among 298 other COVID-19 trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04360538, a study of COVID-19 and Critical Illness, is active but no longer recruiting, sponsored by University of Chicago.
- ACTIVE NOT RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators hypothesize that those with respiratory failure due to COVID-19 will have different burdens of mental and physical disability than those with respiratory failure who do not have COVID-19. Detecting these potential differences will lay an important foundation for treating long term sequelae of respiratory failure in these two cohorts.
Primary Outcome
SF-36 score
Conditions Studied
Interventions
- OTHER Quality of Life
- OTHER Impact Event Score
- OTHER Hospital anxiety and depression scale
Study Locations (1)
Illinois
- University of Chicago Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2020-04-08 |
| Est. Completion | 2026-06-01 |
What the registry record for NCT04360538 still lists
NCT04360538 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 38,463-participant average among 298 other COVID-19 trials with a reported enrollment target (99% lower).
The record links to 4 conditions, with COVID-19 appearing as the primary indexed condition, and to 3 interventions - of which Quality of Life is the first listed.
NCT04360538 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT04360538 about?
NCT04360538 is a clinical study titled "Long Term Outcomes of Patients With COVID-19". The investigators hypothesize that those with respiratory failure due to COVID-19 will have different burdens of mental and physical disability than those with respiratory failure who do not have COVID-19. Detecting these potential differences will lay an important foundation for treating long term ...
What is the current status of trial NCT04360538?
This trial is currently active not recruiting. The enrollment target is 500 participants. The study started on 2020-04-08. Estimated completion is 2026-06-01.
What conditions does trial NCT04360538 study?
This clinical trial studies the following conditions: COVID-19, Critical Illness, Respiratory Failure, Corona Virus Infection.
What interventions are being tested in trial NCT04360538?
The interventions under investigation include: Quality of Life (OTHER), Impact Event Score (OTHER), Hospital anxiety and depression scale (OTHER).
Who is sponsoring clinical trial NCT04360538?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04360538 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04360538's enrollment target sits among peer trials
500 111th of 298 higher than 186 of 298 other COVID-19 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Arginine Replacement Therapy in COVID-19
RECRUITING · Phase 2
-
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
RECRUITING · Phase 2
-
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
RECRUITING
-
COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise
RECRUITING
-
The Impact of COVID-19 on Maternal and Neonatal Outcomes
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI